RnR Market Research

Key Players in Ageing Therapeutics Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com

RnRMarketResearch.com adds “Ageing – Pipeline Review, H1 2015” to its store. The report provides an overview of the Ageing’s therapeutic pipeline.

 

Dallas, TX -- (SBWIRE) -- 06/03/2015 -- The report "Ageing – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Ageing, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ageing and special features on late-stage and discontinued projects. Complete report on H1 2015 pipeline review of Interstitial Cystitis (Painful Bladder Syndrome) with 20 market data tables and 14 figures, spread across 49 pages is available at http://www.rnrmarketresearch.com/ageing-pipeline-review-h1-2015-market-report.html

Companies discussed in this Ageing – Pipeline Review, H1 2015 report include Bioo Therapeutics, Neuralstem, Inc., RepliCel Life Sciences, Inc., RXi Pharmaceuticals Corporation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are BIOO-4, BIOO-7, Drugs for Ageing, metformin + sirolimus, MG-29, MMP-26051, MMP-26052, NSI-189, RCS-01, sirolimus, Small Molecule for Alzheimer's Disease and Ageing, Small Molecules to Activate Telomerase for ALS, GVHD, Ageing and Leukemia, TM-5441.

Order a purchase copy of this report
http://www.rnrmarketresearch.com/contacts/purchase?rname=388744
(This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases: Oct 09, 2014: RepliCel to Present Commercial and Clinical Update on RCS-01 at BioJapan 2014 World Business Forum.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

List of Tables
Number of Products under Development for Ageing, H1 2015 8
Number of Products under Development for Ageing - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Ageing - Pipeline by Bioo Therapeutics, H1 2015 16
Ageing - Pipeline by Neuralstem, Inc., H1 2015 17
Ageing - Pipeline by RepliCel Life Sciences, Inc., H1 2015 18
Ageing - Pipeline by RXi Pharmaceuticals Corporation, H1 2015 19
Assessment by Monotherapy Products, H1 2015 20
Assessment by Combination Products, H1 2015 21
Number of Products by Stage and Target, H1 2015 23
Number of Products by Stage and Mechanism of Action, H1 2015 25
Number of Products by Stage and Route of Administration, H1 2015 27
Number of Products by Stage and Molecule Type, H1 2015 29
Ageing Therapeutics - Recent Pipeline Updates, H1 2015 43
Ageing - Dormant Projects, H1 2015 46

List of Figures
Number of Products under Development for Ageing, H1 2015 8
Number of Products under Development for Ageing - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Monotherapy Products, H1 2015 20
Number of Products by Top 10 Targets, H1 2015 22
Number of Products by Stage and Top 10 Targets, H1 2015 23
Number of Products by Top 10 Mechanism of Actions, H1 2015 24
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 25
Number of Products by Top 10 Routes of Administration, H1 2015 26
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 27
Number of Products by Top 10 Molecule Types, H1 2015 28
Number of Products by Stage and Top 10 Molecule Types, H1 2015 29

Explore more reports on Ophthalmology therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.